Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04130971

Predicting Colorectal Cancer - Tissue Samples to Evaluate Tumour Characteristics and Treatment Response

All adult patients with colorectal cancer presenting within the Sahlgrenska University Hospital or treated at any time at Sahlgrenska University Hospital are eligible and will be asked to participate. We already have biopsies taken at surgery in patients that receive surgery, but this study will include all patients and the biopsies will be taken during endoscopy for diagnosis of the primary tumour. Biopsies will then be taken during follow-up exams prior surgery but after neoadjuvant treatment. Biopsies will also be taken during surgery and in cases where surgery is not necessary biopsies will be taken regularly during follow-up exams.

Blood samples and in relevant cases urinary samples and mouth swabs will be taken at all timepoints when biopsies are taken. If it is not possible to take biopsies prior treatment blood samples will still be drawn.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Dept. of Surgery, Sahlgrenska University Hospital/Ostra

Gothenburg, SE 416 85, Sweden

Location status: Recruiting

Location contact

Eva Angenete, MD,PhD

CONTACT

[email protected]

+46313438410

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Colorectal cancer

Exclusion criteria

  • Not colorectal cancer

Treatment and study plan

No intervention, just observation

Other

No intervention, just observation of the differences between groups and within patients.

Primary outcomes

  1. Tumour response to treatment

    Time frame: 1-2 months after initiated treatment

    Tumour microenviroment changes

Secondary outcomes

  1. Normal tissue response to treatment

    Time frame: 1month -3 years after treatment

    Extra cellular matrix changes

Study contacts

Contact information is provided by the study sponsor or research team.

Eva Angenete

CONTACT

[email protected]

0760514441

Sponsors and collaborators

Lead sponsor

Sahlgrenska University Hospital

Other

Collaborators

  • Göteborg University

Registry information

Official study title

Predict - a Translational Study to Predict Tumour Response to Neoadjuvant Treatment

Acronym: Predict

Important dates

Study start
2019
Primary completion
2025
Study completion
2027
First posted
Oct 18, 2019
Registry last updated
Nov 7, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.